Latest Announcements

Gillette India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with sales up 11% and PAT up 9% compared to the same period last year.

Gillette India Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with sales up 11% and PAT up 9%.

Apcotex Industries Ltd has released its Q1-FY27 earnings presentation, showcasing a 40% year-on-year growth in revenue from operations, driven by higher price realisations despite lower sales volumes. The company delivered its strongest quarterly financial performance with the highest-ever EBITDA, PBT, and PAT in its history. However, export volumes were impacted by geopolitical tensions in West Asia and resulting logistics disruptions.

Vedanta Power Ltd has published unaudited financial results for the first quarter ended June 30, 2026, with net profit for the period after tax at Rs 140.83 crore, up from Rs 597.73 crore in the same quarter last year.

eMudhra Ltd has announced its Q1 FY2027 financial results, with revenue growth of 27.8% YoY and EBITDA growth of 40.4% YoY. The company's adjusted EBITDA margin improved to 27.5% and adjusted PAT margin to 17.6%. The company's business overview highlights its three lines of business: trust services, enterprise solutions, and services, with a focus on AI trust and governance.

Hester Biosciences Ltd announced its unaudited financial results for Q1 FY27, with standalone revenue up 14% and profit up 88%, and consolidated revenue down 8% and profit up 459% due to an exceptional gain from the amendment of the Gates Foundation loan.

JTL Defence Ltd reported a 39.4% QoQ increase in revenue from operations to Rs. 212 Mn in Q1 FY27, driven by improved business operations. EBITDA was Rs. 25 Mn with a margin of 11.6%, and adjusted PAT was Rs. 1 Mn, excluding additional depreciation of Rs. 28 Mn on revalued assets.

Hester Biosciences Limited has announced its unaudited standalone and consolidated financial results for the quarter ended 30 June 2026, showing a 14% increase in standalone revenue and an 88% increase in standalone profit, while consolidated revenue decreased by 8% and consolidated profit increased by 459% due to an exceptional gain from the amendment of the Gates Foundation loan at Hester Africa.

Apcotex Industries Limited has released its Q1-FY27 earnings presentation, showcasing a 40% year-on-year growth in revenue from operations, driven by higher price realisations despite lower sales volumes. The company delivered its strongest quarterly financial performance with the highest-ever EBITDA, PBT, and PAT in its history. However, export volumes were impacted by geopolitical tensions in West Asia, and working capital requirements increased due to elevated raw material prices.

eMudhra Limited has informed the Exchange about Investor Presentation, providing a summary of the company's financial results for the quarter ended June 30, 2026, and highlighting its growth in revenue and profitability, with an increasing focus on product-led growth.

Hester Biosciences Ltd has announced its financial results for the quarter ended 30 June 2026, with a profit of INR 147.11 crore and a total comprehensive income of INR 147.11 crore. The company's revenue from operations was INR 726.60 crore, with a segment-wise revenue of INR 18.16 crore from Poultry Healthcare and INR 108.44 crore from Animal Healthcare. The company's segment results were INR 236.72 crore, with a profit before tax of INR 197.52 crore.

Associated Alcohols & Breweries Ltd. has informed the Exchange about Transcript of Earning/ Investor Conference Call held on 27th July 2026 on Earnings Presentation for the Q1 FY 2026-27. The company reported its highest ever quarterly IMFL proprietary revenue of INR729 million, registering a robust 58% year-on-year growth in value and 40% year-on-year growth in volume.

Hester Biosciences Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a profit before exceptional items and tax of ₹197.52 crore and a profit after exceptional item and tax of ₹147.11 crore. The company has also announced the divestment of 43.81% equity shareholding in its subsidiary, Texas Lifescience Private Limited.

Hester Biosciences Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended 30 June 2026. The company's revenue from operations was INR 26.60 crore, with a net profit of INR 147.11 crore. The results were approved by the Board of Directors in a meeting held on 30 July 2026.

Associated Alcohols & Breweries Ltd reported Q1 FY 2026-27 earnings, with IMFL proprietary segment delivering strong momentum, registering a 58% year-on-year growth in value and 40% year-on-year growth in volume.

Laurus Labs Limited has hosted a Q1 FY27 earnings conference call, discussing strong growth momentum, with revenue of INR2,026 crores, a 29% growth, and EBITDA margins expanding to 31.8%. The company has also signed a development and commercial agreement with Aarvik Therapeutics for 2 ADC molecules and onboarded a big pharma client.

Laurus Labs Ltd reported Q1 FY27 earnings, with revenue of INR2,026 crores, a 29% growth, driven by commercial supplies in CDMO segment and continued strength in affordable medicine portfolio. Gross margins were healthy at 62.7%, and EBITDA margins expanded to 31.8%. The company signed a development and commercial agreement with Aarvik Therapeutics for 2 ADC molecules for India markets, and onboarded a big pharma client with significant opportunities ahead.

Rossell Techsys Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations surging 78% year-on-year to ₹154.7 crore, and profit before tax (PBT) soaring 139% year-on-year to ₹9.60 crore.

Rossell Techsys Ltd reported a record-breaking Q1 FY27 with 78% revenue growth and 139% PBT growth, driven by disciplined execution, expanding customer engagements, and sustained momentum across its core businesses.

Chemfab Alkalis Ltd has submitted an investor presentation for the quarter ended June 30, 2026, highlighting improved ECU realisations, a rise in global caustic prices, and a positive outlook for the Chlor-Alkali business.